Overview
The primary aim of this implementation-effectiveness trial is to examine the effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE) and patient-centered chronic pain management visits in primary care as interventions to reduce chronic pain, improve quality of life, and reduce opioid-related harms among chronic pain patients on long-term opioid therapy.
Eligibility
Inclusion Criteria:
- Age 18 +
- Current chronic pain diagnosis (pain for ≥3 months) determined by physician assessment
- Prescribed long-term opioid therapy (≥3 months)
- Score >=3 on the Pain Enjoyment General Activity scale
- Score >=9 on the Current Opioid Misuse Measure OR lifetime psychiatric or substance use disorder diagnosis OR benzodiazepine use OR history of overdose OR patient or physician determination that risks of opioid use may outweigh the benefits of opioid use
Exclusion Criteria:
- Chronic pain due to a cancer diagnosis
- Active suicidal intent, schizophrenia, psychotic disorder
- Prior experience with Mindfulness-Based Stress Reduction, Mindfulness-Based Cognitive Therapy, Mindfulness-Based Relapse Prevention, or Mindfulness-Oriented Recovery Enhancement